Samjin Pharmaceuticals Market Cap

Samjin Pharmaceuticals has a market cap or net worth of 240.37 billion as of February 20, 2026. Its market cap has increased by 13.95% in one year.

Market Cap

240.37B

Enterprise Value

n/a

Revenue

274.03B

Ranking

n/a

PE Ratio

11.35

Stock Price

19,610.00

Market Cap Chart

Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 240.37B, an increase of 725.47%. That is a compound annual growth rate of 7.17%.

Market Cap History

Date	Market Cap	% Change
Feb 19, 2026	240.37B	-0.71%
Dec 30, 2025	242.09B	9.24%
Dec 30, 2024	221.61B	-19.69%
Dec 28, 2023	275.94B	-19.80%
Dec 29, 2022	344.07B	5.06%
Dec 30, 2021	327.51B	-3.49%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Boditech Med	280.57B
Suheung	271.31B
Daewon Pharmaceutical	251.20B
Chong Kun Dang Holdings	249.93B
Ilyang Pharmaceutical Co.,Ltd	233.92B
HLB Pharmaceutical	227.34B
Samil Pharmaceutical Co.,Ltd	222.49B
AptaBio Therapeutics	220.53B

Market Cap Rankings